Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
SUSPENDED
NCT06503471
PHASE1

SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility

Sponsor: Sclnow Biotechnology Co., Ltd.

View on ClinicalTrials.gov

Summary

To explore the therapeutic effect and safety of human umbilical cord mesenchymal stem cells on thin endometrial infertility and to explore whether human umbilical cord mesenchymal stem cells using collagen as the carrier can promote endometrial growth, reduce the recurrence rate of intrauterine adhesion, increase the clinical pregnancy rate, improve the pregnancy outcome, and study its safety.

Official title: A Clinical Research on SCLife®-UT hUC-MSCs Advanced Therapy Medicinal Products (hUC-MSCs ATMPs) for Patients With Thin Endometrial Infertility

Key Details

Gender

FEMALE

Age Range

20 Years - 39 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2026-12-31

Completion Date

2027-12-31

Last Updated

2026-04-23

Healthy Volunteers

No

Interventions

BIOLOGICAL

human umbilical cord mesenchymal stem cell complex collagen

1 \* 10\^7 cells (2ml)

PROCEDURE

intrauterine injection

intrauterine injection with human umbilical cord mesenchymal stem cell (19#iSCLife®-UT); total 1 time

Locations (1)

Changsha Reproductive Medicine Hospital (Changsha Ning 'er Maternity Hospital)

Changsha, Hunan, China